Literature DB >> 21538683

Gsx transcription factors repress Iroquois gene expression.

Emily F Winterbottom1, Simon A Ramsbottom, Harry V Isaacs.   

Abstract

We have previously shown that the Gsx family homeobox gene Gsh2 is part of the regulatory network specifying dorsoventral pattern of primary neurons in the developing amphibian embryo. Here, we investigate the role of Gsx transcription factors in regulating the transcription of Iroquois family homeobox genes in the amphibian neural plate. Iroquois genes are key regulators of neural patterning and their expression is coincident with that of the Gsx genes during open neural plate stages. We show that Gsx proteins repress Iroquois expression in the embryo and conversely, inhibition of Gsx activity with either antisense morpholino oligos or an anti-morphic Gsx protein up-regulates Iroquois expression. These data indicate that Gsx factors act as negative regulators of Iroquois gene expression in the amphibian neural plate and support a model in which the Gsx proteins promote neuronal differentiation by repressing the expression of known inhibitors of neuronal differentiation such as Iro3.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538683     DOI: 10.1002/dvdy.22648

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  2 in total

1.  Physical interactions between Gsx2 and Ascl1 balance progenitor expansion versus neurogenesis in the mouse lateral ganglionic eminence.

Authors:  Kaushik Roychoudhury; Joseph Salomone; Shenyue Qin; Brittany Cain; Mike Adam; S Steven Potter; Masato Nakafuku; Brian Gebelein; Kenneth Campbell
Journal:  Development       Date:  2020-04-10       Impact factor: 6.862

2.  Conserved Gsx2/Ind homeodomain monomer versus homodimer DNA binding defines regulatory outcomes in flies and mice.

Authors:  Joseph Salomone; Shenyue Qin; Temesgen D Fufa; Brittany Cain; Edward Farrow; Bin Guan; Robert B Hufnagel; Masato Nakafuku; Hee-Woong Lim; Kenneth Campbell; Brian Gebelein
Journal:  Genes Dev       Date:  2020-12-17       Impact factor: 11.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.